Avatar Image

Professor Pamela Russell

Faculty of Health,
School - Biomedical Sciences,
Research - Biomedical Sciences

Personal

Name
Professor Pamela Russell
Position(s)
Professor
Faculty of Health,
School - Biomedical Sciences,
Research - Biomedical Sciences
IHBI Membership
Institute of Health Biomedical Innovation (IHBI),
IHBI Health Projects,
IHBI Biomedical Sciences - CDA
Discipline *
Biochemistry and Cell Biology, Microbiology, Other Biological Sciences
Phone
+61 7 3443 7240
Fax
+61 7 3176 7440
Email
Location
View location details (QUT staff and student access only)
Qualifications

PhD (The University of Melbourne)

Professional memberships
and associations

Membership of Professional Societies

Current Member of Australian Society for Immunology
Current Associate member of American Association for Cancer Research
Current Member of Clinical Oncology Society of Australia
Current Founding Member, Genitourinary Cancer Urological Group
1998-1999 Vice-Chairman, Genitourinary Cancer Urological Group
Current Urological Society of Australasia:  Associate Member
Current Gene Therapy group of NSW now Australian Society for Gene Therapy
1998 Executive Member, Australian Society for Gene Therapy
2007-2010 Secretary and Director, ANZUP Australian and New Zealand Prostate and Urological Cancer Clinical Trials Group Ltd

Leadership in Professional Societies and Associations

1977-1978 Qualifications Committee of the Austrlaian Society of Microbiology
1979 Education Officer of the Australian society of Microbiology for ACT
1991 Member of Research Committee of COSA
1993 Founding member of Genitourinary Oncology Group GUOG
1995-1996 Secretary, GUOG
1998-1999 Vice-Chairman, GUOG
1998 Executive, Gene Therapy Group, NSW
1998-2000 Board Member, Prostate Cancer Research Foundation
2002- Member of Bioresource Committee, APCC
2004- Executive Member, APCC
2002-2004 Member of Board of Management of Biological Resources Centre (BRC), UNSW
2004-2006 Member of Advisory Committee of Biological Resources (BRAAG), UNSW
2004- Member of IP Committee, St Vincents Hospital, Sydney
2003-2006 Member of Cancer Care Committee, South Eastern Sydney Area Health Service
2005-2006 Executive member, Scientific steering Committee, Prostate Cancer Foundation of Australia
2006- Executive Member, Urological Oncology Program, NSW Cancer Institute
2007-2010 Secretary, Director, Australian Prostate and Urological Cancer Clinical Trials Group, ANZUP
Keywords

bony metastasis, gene therapy, imaging using nanoparticles, prostate cancer, prostate cancer animal models

* Field of Research code, Australian and New Zealand Standard Research Classification (ANZSRC), 2008

Biography

Prof Russell joined the Australian Prostate Cancer Research Centre – Queensland (APCRC–Q) in 2009 where she holds the position of Professor, Head of Biomedical Imaging and Prostate Cancer Models. Prof Russell is a member of the Institute of Health and Biomedical Innovation, Queensland University of Technology working in translational studies in prostate cancer. Her current work focuses on the development of new animal models to study bony metastasis from prostate cancer. Prof Russell also investigates the development of theranostics, – nanotechnology for real time imaging for diagnosis and therapeutic delivery, including gene therapy of prostate cancer, and finding biomarkers from exosomes to predict treatment response in patients undergoing therapy.
Prof Russell trained in immunology at Walter & Eliza Hall Institute, where she obtained an MSc with Sir Macfarlane Burnet and a PhD with Sir Gustav Nossal, on studies of autoimmune diseases. She then trained at John Curtin School of Medical Research, Canberra, and at Kolling Institute of Medical Research. In 1984, Prof Russell changed her research focus to cancer and, with Dr Derek Raghavan, established the Urological Cancer Research Centre at Royal Prince Alfred Hospital/University of Sydney. Prof Russell then directed the Oncology Research Centre (ORC), Prince of Wales Hospital from 1992 to 2010, as conjoint Professor of Medicine, University of New South Wales (UNSW).
Prof Russell has built an international reputation for work on bladder and prostate cancer, with expertise for establishing cell lines and rare xenografts from primary human tumours. She collaborates widely, within Australia and overseas in USA and Europe.
She has supervised several postgraduate students, and since 2008 she has delivered presentations or chaired sessions at 14 international prostate cancer meetings.
Nationally, she helped to initiate the Australian Genitourinary Oncology Group and the Prostate Cancer Foundation of Australia (PCFA) (of which she is a life member). From 2007 to 2010 Prof Russell served as an inaugural Director/Secretary of the Australasian Urological and Prostate Cancer Clinical Trials Group (ANZUP). She is also an Australian editor for Urological Research and a member of Movember’s Global Scientific Committee.
Prof Russell has been on peer review committees for the National Health and Medical Research Committee (NHMRC), Cancer Council Australia, Cure Cancer Australia, and regularly reviews papers from international journals.
Research theme: Health
Research discipline: Cell and Molecular Biosciences
This information has been contributed by Professor Pamela Russell.

Research projects

Grants and projects (Category 1: Australian Competitive Grants only)

Title
Immuno-Polymeric Drugs for Prostate Cancer Therapy
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
APP1099321
Start year
2016
Keywords
Title
The Microniche: A Novel In-vitro and In-vivo Prostate Cancer Model System
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
APP1108043
Start year
2016
Keywords
Prostate Cancer, Metastatic Cancer, Bone Marrow, Stem Cell Biology, Hormone-refractory Prostate Cancer
Title
Next Generation Hybrid Nanomaterials: Bispecific Antibody-Targeted Polymers
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
LP150100703
Start year
2015
Keywords
Title
Novel prostate cancer target for diagnosis, imaging, detection of recurrence and response to therapy
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
1093539
Start year
2015
Keywords
Diagnostic, Gcp1, Imaging Agent, Prostate Cancer, Therapy
Title
Imaging Prostate Cancer Theranostics
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
1046831
Start year
2013
Keywords
imaging, prostate cancer, diagnosis, drug delivery, cancer staging
Title
Simultaneous Imaging and Drug Delivery for Prostate Cancer Theranostics
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
NDDA 0411
Start year
2012
Keywords
19f-Mri, Targeted Drug Delivery, Drug Conjugated Hyperbranched Polymers, Prostate Cancer Imaging, Theranostics
Title
To Identify a New Therapeutic Target for the Treatment of Prostate Cancer
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
1031228
Start year
2012
Keywords
prostate cancer, invasion, epithelial-mesenchymal transition (EMT), protein kinases, targeted therapy
Title
To Study how Prostate Tumor Metastasizes to Bone
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
1031221
Start year
2012
Keywords
Prostate Cancer, Bone Metastasis, Stem Cells, Microrna, Epithelial-mesenchymal Transition (EMT)
Title
KLK4 is a Master Regulator of Tumour Microenvironment Remodelling in Prostate Cancer and Bone Metastasis
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
1010141
Start year
2011
Keywords
Kallikrein, Prostate Cancer, KLK4, PROTOMAP, 3D Gell Matrices, TAILS
Title
Evaluation of the Therapeutic Potential of SFTI-FCQR, a Novel Kallikrein 4-Specific Protease Inhibitor
Primary fund type
CAT 1 - Australian Competitive Grant
Project ID
497270
Start year
2008
Keywords
Ovarian Cancer, Prostate Cancer, Androgens, Kallikreins, Protease Inhibitors